ABVC Biopharma Valuation
| ABVC Stock | USD 1.73 0.01 0.57% |
Based on Macroaxis valuation methodology, the entity appears to be fairly valued. ABVC Biopharma shows a prevailing Real Value of $1.8 per share. The current price of the entity is $1.73. Our model approximates the value of ABVC Biopharma from reviewing the entity fundamentals such as Operating Margin of (1.47) %, shares owned by insiders of 10.70 %, and Return On Asset of -0.17 as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ABVC Biopharma's valuation include:
Price Book 3.5673 | Enterprise Value | Enterprise Value Ebitda (1.90) | Price Sales 52.9929 | Enterprise Value Revenue 55.3279 |
Fairly Valued
Today
Please note that ABVC Biopharma's price fluctuation is dangerous at this time. Calculation of the real value of ABVC Biopharma is based on 3 months time horizon. Increasing ABVC Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ABVC Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ABVC Stock. However, ABVC Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.73 | Real 1.8 | Target 2.02 | Hype 1.62 |
The real value of ABVC Stock, also known as its intrinsic value, is the underlying worth of ABVC Biopharma Company, which is reflected in its stock price. It is based on ABVC Biopharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ABVC Biopharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ABVC Biopharma helps investors to forecast how ABVC stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ABVC Biopharma more accurately as focusing exclusively on ABVC Biopharma's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ABVC Biopharma's intrinsic value based on its ongoing forecasts of ABVC Biopharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ABVC Biopharma's closest peers. If more than one evaluation category is relevant for ABVC Biopharma we suggest using both methods to arrive at a better estimate.
ABVC Biopharma Cash |
|
ABVC Biopharma Total Value Analysis
ABVC Biopharma is presently anticipated to have valuation of 44.15 M with market capitalization of 42.28 M, debt of 3.2 M, and cash on hands of 2.99 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the ABVC Biopharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
44.15 M | 42.28 M | 3.2 M | 2.99 M |
ABVC Biopharma Investor Information
The book value of the company was presently reported as 0.51. The company recorded a loss per share of 0.28. ABVC Biopharma last dividend was issued on the 8th of May 2019. The entity had 1:10 split on the 25th of July 2023. Based on the key measurements obtained from ABVC Biopharma's financial statements, ABVC Biopharma is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.ABVC Biopharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ABVC Biopharma has an asset utilization ratio of 6.76 percent. This indicates that the Company is making $0.0676 for each dollar of assets. An increasing asset utilization means that ABVC Biopharma is more efficient with each dollar of assets it utilizes for everyday operations.ABVC Biopharma Profitability Analysis
Based on the key profitability measurements obtained from ABVC Biopharma's financial statements, ABVC Biopharma may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess ABVC Biopharma's ability to earn profits and add value for shareholders.Net Loss | First Reported 2002-06-30 | Previous Quarter -2.3 M | Current Value -1.2 M | Quarterly Volatility 1.8 M |
For ABVC Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of ABVC Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well ABVC Biopharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between ABVC Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of ABVC Biopharma over time as well as its relative position and ranking within its peers.
ABVC Biopharma Earnings per Share Projection vs Actual
By analyzing ABVC Biopharma's earnings estimates, investors can diagnose different trends across ABVC Biopharma's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for ABVC Biopharma is based on EPS before non-recurring items and includes expenses related to employee stock options.ABVC Biopharma Ownership Allocation
ABVC Biopharma holds a total of 24.3 Million outstanding shares. ABVC Biopharma shows 10.7 percent of its outstanding shares held by insiders and 3.14 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.ABVC Biopharma Profitability Analysis
The company reported the previous year's revenue of 509.59 K. Net Loss for the year was (5.26 M) with profit before overhead, payroll, taxes, and interest of 797.92 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ABVC Biopharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ABVC Biopharma and how it compares across the competition.
About ABVC Biopharma Valuation
The stock valuation mechanism determines ABVC Biopharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of ABVC Biopharma. We calculate exposure to ABVC Biopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ABVC Biopharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 585.1 K | 614.4 K | |
| Pretax Profit Margin | (12.12) | (12.72) | |
| Operating Profit Margin | (8.31) | (8.73) | |
| Net Loss | (11.06) | (11.62) | |
| Gross Profit Margin | 0.90 | 0.94 |
ABVC Biopharma Current Valuation Indicators
Valuation refers to the process of determining the present value of ABVC Biopharma and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ABVC we look at many different elements of the entity such as ABVC's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ABVC Biopharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ABVC Biopharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ABVC Biopharma's worth.Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |